Lovastatin is a potent inhibitor of cholecystokinin secretion in endocrine tumor cells in culture

Peptides

Volumn 21, Issue 4, 2000, Pages 553-557

  Vishnuvardhan, Daesety ^a   Beinfeld, Margery C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cholecystokinin; Lovastatin; Prenylation

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ OCTAPEPTIDE; FORSKOLIN; MEVALONIC ACID; MEVINOLIN;

ANIMAL CELL; ARTICLE; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; ENDOCRINE TUMOR; GASTROINTESTINAL TOXICITY; HORMONE RELEASE; NONHUMAN; PRENYLATION; PRIORITY JOURNAL; PROTEIN TRANSPORT; TUMOR CELL CULTURE;

ANIMALS; ENDOCRINE GLAND NEOPLASMS; FORSKOLIN; LOVASTATIN; MEVALONIC ACID; MICE; RATS; SINCALIDE; TUMOR CELLS, CULTURED;

EID: 0034098582     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00168-6     Document Type: Article

References (38)

1. Adamson P., Marshall C.J., Hall A., Tilbrook P.A. Post-translational modifications of p21rho proteins. J Biol Chem. 267:1992;20033-20038.
2. Beinfeld M.C. Cholecystokinin (CCK) gene-related peptides distribution and characterization of immunoreactive pro-CCK and an amino-terminal pro-CCK fragment in rat brain . Brain Res. 344:1985;351-355.
3. Beinfeld M.C. CCK mRNA expression, pro-CCK processing and regulated secretion of immunoreactive CCK peptides by rat insulinoma cells (RIN 5F) and mouse pituitary tumor (AtT20) cells in culture. Neuropeptides. 22:1992;213-217.
4. Beinfeld M.C. CCK biosynthesis and processing recent progress and future challenges . Life Sci. 61:1997;2359-2366.
5. Beinfeld M.C. Cholecystokinin/gastrin. In. 1998;Lippincott-Raven Press, Watson JS, editor. Psychopharmacology, chapt. 56, CD/ROM ed. Philadelphia.
6. Beinfeld M.C., Haun R.S., Allard L.R., Dixon J.E. Regulation of cholecystokinin secretion from a rat thyroid medullary carcinoma cell line role of calcium, cyclic nucleotides, glucocorticoids, neurotensin, and calcitonin gene-related peptide . Peptides. 13:1992;545-590.
7. Beinfeld M.C., Meyer D.K., Eskay R.L., Jensen R.T., Brownstein M.J. The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay. Brain Res. 212:1981;51-57.
8. Beinfeld M.C., Perloff M.D., Venkatakrishnan K. Identification of glycine-extended CCK peptides in endocrine cells and modulation of CCK amide and CCK Gly content and secretion from endocrine tumor cells by an inhibitor of amidation. Peptides. 19:1998;1393-1398.
9. Bhullar R.P. Expression of a 24 kDa GTP-binding protein (Gn24) is increased in lovastatin treated human erythroleukemia cells. Mol Cell Biochem. 156:1996;59-67.
10. Boguski M.S., McCormick F. Proteins regulating Ras and its relatives. Nature. 366:1993;643-654.
11. Burgering B.M., Bos J.L. Regulation of Ras-mediated signalling more than one way to skin a cat . Trends Biochem Sci. 20:1995;18-22.
12. Buss J.E., Quilliam L.A., Kato K., Casey P.J., Solski P.A., Wong G., Clark R., McCormick F., Bokoch G.M., Der C.J. The COOH-terminal domain of the Rap1A (Krev-1) protein is isoprenylated and supports transformation by an H-Ras:Rap1A chimeric protein. Mol Cell Biol. 11:1991;1523-1530.
13. Casey P.J., Solski P.A., Der C.J., Buss J.E. p21ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci USA. 86:1989;8323-8327.
14. Chakrabarti R., Engleman E.G. Interrelationships between mevalonate metabolism and the mitogenic signaling pathway in T lymphocyte proliferation. J Biol Chem. 266:1991;12216-12222.
15. Chiloeches A., Lasa M., Brihuega F., Montes A., Toro M.J. Effects of lovastatin on adenylyl cyclase activity and G proteins in CH4C1 cells. FEBS Lett. 361:1995;46-50.
16. Cutts J.L., Bankhurst A.D. Suppression of lymphoid cell function in vitro by inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by lovastatin. Int J Immunopharmacol. 11:1989;863-869.
17. Epstein W.W., Lever D., Leining L.M., Bruenger E., Rilling H.C. Quantitation of prenylcysteines by a selective cleavage reaction. Proc Natl Acad Sci USA. 88:1991;9668-9670.
18. Farnsworth C.C., Wolda S.L., Gelb M.H., Glomset J.A. Human lamin B contains a farnesylated cysteine residue. J Biol Chem. 264:1989;20422-20429.
19. Ghosh P.M., Mott G.E., Ghosh-Choudhury N., Radnik R.A., Stapleton M.L., Ghidoni J.J., Kreisberg J.I. Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells. Biochim Biophys Acta. 1359:1997;13-24.
20. Hancock J.F., Magee A.I., Childs J.E., Marshall C.J. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell. 57:1989;1167-1177.
21. Haun R.S., Beinfeld M.C., Roos B.A., Dixon J.E. Establishment of a cholecystokinin-producing rat medullary thyroid carcinoma cell line. Endocrinology. 125:1989;850-856.
22. Hori Y., Kikuchi A., Isomura M., Katayama M., Miura Y., Fujioka H., Kaibuchi K., Takai Y. Post-translational modifications of the C-terminal region of the rho protein are important for its interaction with membranes and the stimulatory and inhibitory GDP/GTP exchange proteins. Oncogene. 6:1991;515-522.
23. Ivessa N.E., Gravotta D., De Lemos-Chiarandini C., Kreibich G. Functional protein prenylation is required for the brefeldin A-dependent retrograde transport from the Golgi apparatus to the endoplasmic reticulum. J Biol Chem. 272:1997;20828-20834.
24. Kawata M., Farnsworth C.C., Yoshida Y., Gelb M.H., Glomset J.A., Takai Y. Posttranslationally processed structure of the human platelet protein smg p21B evidence for geranylgeranylation and carboxyl methylation of the C-terminal cysteine . Proc Natl Acad Sci USA. 87:1990;8960-8964.
25. Khosravi-Far R., Lutz R.J., Cox A.D., Conroy L., Bourne J.R., Sinensky M., Balch W.E., Buss J.E. , Der CJ. Isoprenoid modification of rab proteins terminating in CC or CXC motifs. Proc Natl Acad Sci USA. 88:1991;6264-6268.
26. Kinsella B.T., Erdman R.A., Maltese W.A. Carboxyl-terminal isoprenylation of ras-related GTP-binding proteins encoded by rac1, rac2, and ralA. J Biol Chem. 266:1991;9786-9794.
27. Kinsella B.T., Maltese W. A rab GTP-binding proteins implicated in vesicular transport are isoprenylated in vitro at cysteines within a novel carboxyl-terminal motif. J Biol Chem. 266:1991;8540-8544.
28. Kinsella B.T., Maltese W.A. rab GTP-binding proteins with three different carboxyl-terminal cysteine motifs are modified in vivo by 20-carbon isoprenoids. J Biol Chem. 267:1992;3940-3945.
29. Krukemyer J.J., Talbert R.L. Lovastatin a new cholesterol-lowering agent . Pharmacotherapy. 7:1987;198-210.
30. Marcelli M., Cunningham G.R., Haidacher S.J., Padayatty S.J., Sturgis L., Kagan C., Denner L. Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP. Cancer Res. 58:1998;76-83.
31. Mumby S.M., Casey P.J., Gilman A.G., Gutowski S., Sternweis P.C. G protein gamma subunits contain a 20-carbon isoprenoid. Proc Natl Acad Sci USA. 87:1990;5873-5877.
32. Orci L., Montesano R., Meda P., Malaisse-Lagae F., Brown D., Perrelet A., Vassalli P. Heterogeneous distribution of filipin-cholesterol complexes across the cisternae of the Golgi apparatus. Proc Natl Acad Sci USA. 78:1981;293-297.
33. Pfeffer S.R. Rab GTPases master regulators of membrane trafficking . Curr Opin Cell Biol. 6:1994;522-526.
34. Rothman J.E. Mechanisms of intracellular protein transport. Nature. 372:1994;55-63.
35. Schafer W.R., Kim R., Sterne R., Thorner J., Kim S.H., Rine J. Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans. Science. 245:1989;379-385.
36. Tabacik C., Aliau S. Cholesterogenesis and cell division in phytohemagglutinin-stimulated human lymphocytes a comparative study with several inhibitors . Biochim Biophys Acta. 1011:1989;149-157.
37. Vaughan C.J., Murphy M.B., Buckley B.M. Statins do more than just lower cholesterol. Lancet. 348:1996;1079-1082.
38. Yamane H.K., Farnsworth C.C., Xie H.Y., Howald W., Fung B.K., Clarke S., Gelb M.H., Glomset J.A. Brain G protein gamma subunits contain an all-trans-geranylgeranylcysteine methyl ester at their carboxyl termini. Proc Natl Acad Sci USA. 87:1990;5868-5872.